Eden Research Share Discussion Threads

[erinvale] 29/9/2020 07:50

Much as for the last 20 years: more promises, minimal sales.

[grahamg8] 29/9/2020 07:47

This reminds me of a hamster in its wheel. The more money you feed EDEN the faster it spends it, but at the end of the day an exhausted hamster with its shareholders flop to the bottom of the cage having gone exactly nowhere. Sales up £0.28m overheads up £0.29m. Before you all rush to say but we have products, licences and patents they are meaningless if they can't be turned into profitable sales.

[investingisatrickygame] 29/9/2020 07:20

From the half-year report published today

"Eden's technology and products can solve many of the issues associated with the use of conventional pesticides, including reducing or eliminating the use of microplastics in farming. We continue to make progress towards realising the opportunities identified by the company at the time of the capital raise"

This statement really makes you wonder what's coming from Eden, doesn't it! It is a big, bold statement in my opinion.

"We previously reported our expectations to receive US EPA approval for the sale of Mevalone and Cedroz in the United States during 2020. However, partly due to Covid-19 and consequential operational challenges at the EPA, the approval has disappointingly continued to be delayed and timing remains uncertain. The Company continues to actively engage with providing additional data to the EPA to advance the process and assist where possible."

This doesn't sound like a Covid related excuse to me such as a workforce not at its desk, but something else. I wonder what the 'additional data' requirements are to convince the authorities to grant approvals.

It sounds to me like an insecticide announcement is coming soon from the commentary in the accounts as further commented on under the heading "Outlook"

"Following our successful capital raise in March, Eden is in a good position to capitalise on the work it has done to date and move forward expeditiously with its new, effective insecticide products and pursue other key opportunities in its pipeline. Our work on the development of insecticide formulations has been progressing as expected. We plan to update the market on these promising developments in due course."

It also sounds like the Corteva arrangement is progressing to the positive.

All in all it looks like some big announcements due soon, therefore by December end 2020.

All good.

[supersonico] 29/9/2020 07:16

Half Yearly shortorder parallel Jam Report

Jam / TT / Dupont / Bayer

Work at TerpeneTech continues on the commercial launch of a head lice treatment product. Though the timing of a commercial launch in the UK has become less clear, in part due to issues surrounding Covid-19 and its impact on certain retail product offerings, we do note that TerpeneTech is in advanced conversations with another commercial partner covering numerous territories outside of the UK. This partially validates the strong commercial demand for safe and effective head lice treatment products globally, and it highlights the shortage of products that meet the demand of today's consumers. TerpeneTech's sale of biocidal geraniol continues to develop positively, with demand for biocides strengthening as a result of the Covid-19 pandemic.

JAM / Corteva / Bayer

Our agreement with Corteva Agriscience was Eden's first significant milestone in developing and commercialising, via partnership, a product using Sustaine in the new application area of seed treatments. As announced previously, Corteva currently has until the end of 2020 for the exclusive evaluation of products which use Sustaine in select seed treatment applications. Following this, Corteva may enter into an exclusive agreement for the distribution of products in the EU and potentially several other countries. This would represent a major milestone for Eden as it will be the first use of Eden's products and technology in the treatment of seeds and would be an initial step into this area across a range of functional uses and seed types. Our work with Corteva has progressed largely as planned, and we will update the market on this exciting opportunity as soon as we are able to do so.

[chrischas] 27/9/2020 12:07

Supersonico: That is my fear too! That seems to be the way it is playing out.

The Tremeloes "Silence is Golden" is a good title that should be on Edens website for
investors to listen to while reading their next announcement. But i havent quite got to "oh dont it hurt deep inside" just yet That comes in the short order of any Corteva
announcement.

[supersonico] 26/9/2020 13:41

The messaging is very similar, it also shows the importance of timing of the opportunity and coalescing of technology into the Sustainability mega Trend. The big money behind them knows the direction of travel.

Corteva is the thin end of a paralleldelayedducksinalineinthecomingshortorder fat wedge imo.

[investingisatrickygame] 26/9/2020 11:46

Super said

"Interesting how quick the revenue grew from R&D to commercialisation.

Est 2014
All R&D leading up to 2016 No commercial revenues.
2017..$67m rev.
2018..expected to do $.5B"

Yes, that stood out a mile from the video. For me, I think there were a few major points

1) The $400 million raised
2) Who it was raised from with deep enough pockets to go again
3) That the CEO had built and sold two multi-billion $ companies
4) The size of the opportunity in an undisrupted market

Whilst Eden and Indigo has similar messaging around climate, sustainability et al, Indigo has gone a stage further with the supply chain too, tracking every step and ensuring security of a better quality crop.

It just screams to me that with some more help, one way or another, Eden's fortunes could rise rapidly to become a company worth many hundred's of millions of $'s/£'s.

Corteva, may be the first step in 'help' and raising Eden's revenue, profit and profile.

[supersonico] 26/9/2020 09:26

Belgium’s Superior Health Council Call for Phase-Out of Glyphosate Herbicides

NEED FOR A CONTROLLED, PLANNED AND PROGRESSIVE PHASE OUT OF GLYPHOSATE IN THE INTEREST OF PUBLIC HEALTH

The EU extended the permission for using glyphosate and glyphosate containing formulations till December 2022 with some restrictions and installed the special PEST committee to review the procedure allowing the use of pesticides in the EU. The conclusions of the committee were approved by the EU-Parliament in January 2019. In December 2019, the procedure for extension of the permission using glyphosate in the EU beyond December 2022 has been initiated by a cluster of companies, Bayer being the most important one.

Taking the mission of the Superior Health Council (SHC) into account and being aware of the importance of the glyphosate file, the SHC expresses his point of view on the matter. It is not the aim to perform another systematic review of the scientific literature but rather to obtain a bird’s-eye view on the complexity of the situation and to provide recommendations for Belgian public health authorities. This report was validated by the SHC Board in January 2020. However, the SHC preferred to postpone its publication due to the general – and justified – attention paid to the coronavirus epidemic. In fact, the SHC ‘s role in public health has meant that the Council too has issued advisory reports in the context of the epidemic.

[supersonico] 25/9/2020 19:18

Interesting how quick the revenue grew from R&D to commercialisation.

Est 2014
All R&D leading up to 2016 No commercial revenues.
2017..$67m rev.
2018..expected to do $.5B

[attyg] 25/9/2020 18:46

Indigo is private and so can discuss matters without requiring nomad oversight.
Interesting that the company is valued at over $1 billion.
Perhaps my dreams may be realised in time.

[supersonico] 25/9/2020 10:39

Your right. Indigo Ag need to update their bio page..unless she is freelance.
Interesting Bio includes Bayer for 13 years.
The question I ask is ..how did she come across EDEN?
In my experience these talented ' likes' often end up as employed by Eden or Eden related.
Nothing is random.

[investingisatrickygame] 25/9/2020 10:31

She is no loner at Indigo according to Linkedin

[investingisatrickygame] 25/9/2020 10:22

It does illustrate where Eden could go with the right communication of their investment proposition to the investment community, the right funding and the right product.

Indigo is private, but look what it has achieved in such a short timeframe. Big money clearly buys a) the problem they are addressing, b) the size of the prize and c) that Indigo has the team and the solution(s) to resolve the problem.

[supersonico] 25/9/2020 10:07

Investing,
Yes I agree and made all the more intriguing when an Indigo AG Argentinian colleague
likes Eden on Twitter.




Probably another Fat finger similar Like to the Indian Rice bowl Fella I posted about in 5158.
I wish they would be more careful as it gives the unfashionable impression Unmentionable is earning his wedge.

[investingisatrickygame] 25/9/2020 09:56

Super,

re post 8171, that was a really interesting presentation and speaker. I haven't ventured to look at the Company concerned, but what I liked about it was

1) He qualified his successes at the beginning which was more than significant
2) He qualified his successes in start-up's
3) He cited his interest in Agriculture as it is arguably the most important sector on the planet
4) He said it was the least disrupted sector in all major sectors presented
5) He talked about innovation and incentivisation and then Consumer-Focused Agriculture
6) Selecting a leadership team that looks more like one from a Fortune 500 company than a 4 year-old start-up
7) He said you need to raise a lot of money to solve big problems (very logical)
8) He also talked about agriculture having reached commoditisation and the need to create differentiators which I imagine is true in the first instance (commoditisation) and an obvious business goal in the second instance


Interestingly he talked about people in the middle east being particularly focused on food security. If you look at his investors, he is clearly very well connected or those around him are. Equally the sector, its lack of disruption and his record of building and selling billion $ companies must be very attractive to investors.

Very interesting presentation delivered in a sober way, no pumping the company, just delivering the market facts and opportunity. I'd take a closer look with a view to investing which is what you want as an output from any like presentation.

[supersonico] 24/9/2020 14:07

An interesting presentation focusing on how new innovations fair in a world dominated by Ecocidal behemoths and useful as a lens to consider Eden's evolution/progress/struggles over the inthecomingshortorder years.

Indigo CEO David Perry: On Innovating In Agriculture

[chrischas] 23/9/2020 18:12

I take on board what you have said
But i still feel there is a huge gap. Too many quiet periods and to me they are late on everything. I can see 2-3yrs of just the same
followed by another attempt to patch up the gaps that are still evident I want to see a strategy ,publicised, on how they are driving forward potential sales.

Just because they use Proactive Investors does not mean they are proactive .Where is the vigour and imagination I cannot see it. Neither can the potential end users. Now is the perfect time .
A rocket needs putting up there backsides if they dont get in people who can do that now. They need them in place now with more ideas. It will not wait to get the one or 2people in next year or the year after.

[supersonico] 23/9/2020 14:47

From the alliance AGENCY ICE-FederBio is born Ita.Bio, the first platform for the international development of Italian organic

The aim is to consolidate the positioning of Italian organic agri-food in foreign markets, through the identification of the basket of BIO Made in Italy products with greater potential and the development of e-commerce.

Bologna, 23 September 2020 –ICE – Agency for the Promotion Abroad and Internationalization of Italian Companies,and FederBio,the National Federation of Organic and Biodynamic Agriculture,renew the collaboration in the name of enhancing organic agri-food on international markets. At the heart of the agreement is the activation of the Ita.Bio platform, developed to increase the positioning of Italian organic on international markets and e-commerce channels.

The agreement provides for the promotion of market intelligence solutions aimed at consolidating the process of internationalization of the Italian organic agri-food chain. The partnership aims to offer scenario and competency analysis, support the definition of development policies based on information in the relevant markets, network with the community by sharing knowledge and support the interpretation of the challenges of the global competitive scenario.

The partnership between the two companies has led to the development of the Ita.Bioplatform, an innovative tool for the promotion of BIO Made in Italy on international channels, with particular reference to the USA and China, which aims to identify a basket of Italian organic products with greater potential for expansion at international level and suitable to be enhanced through e-commerce channels.

The Ita.Bio platform has 3 main features: Tracking & Market Measurement, Support for Promotion on International Markets and Communication. Through Tracking & Market Measurement it is possible to monitor the opportunities for organic development in relation to the following parameters: organic numbers, sales trends, consumption models, characteristics and consumer needs of organic products in the target markets, data related to the export of Italian organic and how to buy including the e-commerce channel.

A Business Survey for the Evaluation of Organic Export by Nomisma has been launched for data collection. The first results and a preview of the Survey will be presented in Bologna, at SANA Restart, as part of the Bio Revolution event.

The Ita.Bio Platform's "International Market Promotion Support" feature aims to create up-to-date and fast business intelligence tools to support the presence of the ICE Agency and its network's activity in foreign markets.

In addition, a "FederBio-ICE Desk" has been set up in the Rome office of the ICE Agency to consolidate the activities to support the promotion of organic on the main international markets.

Finally, a joint programme of promotional actions abroad, focused on China and the United States, is planned, with the organization of an institutional and corporate presence at the Ciofe trade shows in Xiamen (November 2020) and Summer Fancy Food in New York (June 2021). In addition, considering the global importance of Biofach, a presence is planned in support of Italian participation in the fair that will take place in Nuremberg in February 2021.


[...]

[attyg] 23/9/2020 13:14

Chriscas

Perhaps Eden has started?


supersonico - 17 Sep 2020 - 19:30:57 - 8138 of 8168 Eden Research - EDEN
Paolo Bravini
Formulation Scientist at Eden Research plc

[...]

[attyg] 23/9/2020 13:11

Below is my cut and paste of extracts from the RNS re the patent granted to Eden in Australia - I have excluded some words and had placed certain sections in bold, sadly that does not come through on ADVFN

Sortudo7 - you will note Brazil is included.




"Eden ….. announces that the patent behind its Sustaine® encapsulation technology has been granted in Australia; the first patent specifically covering the use of Sustaine with third party active ingredients to be granted anywhere in the world.
The patent is for "Encapsulation of High Potency Actives" allowing for the combination of Sustaine with a wide range of active ingredients from third parties. Sustaine microcapsules …. are one of the few viable alternatives to plastic-based microencapsulation technologies which are used widely in fertilisers, encapsulated plant protection products (PPPs), seed coatings, and biocides.
Eden has engaged in a number of projects around the world to test the compatibility of Sustaine with third party active ingredients in order to determine whether benefits such as formulation stability, improved efficacy, dose reduction or resistance management can be achieved. In January 2020, Eden announced an exclusive agreement with Corteva ……to evaluate formulations based upon Sustaine in certain major territories. The patent allows Eden to exploit opportunities of this kind in the Australian market with a patent protected position. ….. Patents are being pursued by Eden in a total of 27 key territories around the world, including the United States, Europe, China and Brazil."

[investingisatrickygame] 23/9/2020 13:10

I think the directors need to be more dynamic and show more flair with the investment community, but it is the job of the appointed distributors to sell product.

Eden's job with the distributors, as I see it, is to ensure the distributors have the right focus and resource behind Eden's products to be able to sell through successfully. If it becomes evident that this is not so, then it's a case of review the distributor and change if necessary.

[supersonico] 23/9/2020 13:03

Did you read my post?

It was a question not to be confused with 'saying sit back and blame their distributors' which is different.

[chrischas] 23/9/2020 12:41

Your saying sit back and blame their distributors. have you seen their lists of products? No your parent company has to push and to be seen by future users.

It’s a symbiotic relationship

[supersonico] 23/9/2020 11:38

Chrischas,
I'm guessing but wouldn't the dynamism you speak of be more important coming from Sipcam / Sumiagro ?

Congrats on the Spanish.